In this episode, Jen, Karan, and Ollie discuss recent newsworthy items, including the political shifts taking place across Europe and their potential impact to the pharma sector, as well as the challenges posed by medicine stockpiling and breakthr

The healthcare industry is in an unprecedented era of change as rapidly advancing technologies, changing consumer expectations, and rising costs force organizations to adapt. With a landscape that is becoming increasingly more competitive, organiz

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the recent ruling by the United States Supreme Court on access to the abortion pill mifepristone, the declaration of bankruptcy by the Massachusetts-based Steward Hea

In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shi

In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.

As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vyna

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role

During Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister

In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University

As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to en